Our genetic risk scoring model was based upon a combination of HSPAL1L, PUM1, UBE2D2, and HSP gene mRNA expressions that were selected from among 186 HRGs to quantitatively predict the prognosis of CRC. This evidence concerns the gene UBE2D2 and colorectal carcinoma.